CureVac's Cash And Cash Equivalents Position Of €300.2M As Of March 31, 2024; Reaffirming Cash Runway Into Fourth Quarter Of 2025
CureVac's Cash And Cash Equivalents Position Of €300.2M As Of March 31, 2024; Reaffirming Cash Runway Into Fourth Quarter Of 2025
截至2024年3月31日,CureVac的現金及現金等價物狀況爲3億歐元;重申現金跑道將持續到2025年第四季度
CureVac's Cash And Cash Equivalents Position Of €300.2M As Of March 31, 2024; Reaffirming Cash Runway Into Fourth Quarter Of 2025
截至2024年3月31日,CureVac的現金及現金等價物狀況爲3億歐元;重申現金跑道將持續到2025年第四季度
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。